Second attempt to withdraw cabergoline in prolactinomas: a pilot study

被引：0
|
作者：
Ratchaneewan Kwancharoen
Renata Simona Auriemma
Gayane Yenokyan
Gary S. Wand
Annamaria Colao
Roberto Salvatori
机构：
[1] Johns Hopkins University School of Medicine,Division of Endocrinology and Metabolism, Department of Medicine, Pituitary Center
[2] Johns Hopkins University School of Public Health,Department of Biostatistics
[3] University “Federico II”,Sezione di Endocrinologia, Dipartimento di Medicina Clinica e Chirurgia
来源：
Pituitary | 2014年 / 17卷
关键词：
Cabergoline; Prolactinoma; Second withdrawal; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：451 / 456
页数：5
相关论文
共 50 条
  • [31] High-dose cabergoline improves pregnancy rates in women with prolactinomas
    Vicky Heath
    Nature Reviews Endocrinology, 2010, 6 (8) : 415 - 415
  • [32] A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas
    Boguszewski, Cesar Luiz
    Correa dos Santos, Carlos Mauricio
    Sakamoto, Kelly Suga
    Marini, Lilian Cassia
    de Souza, Admar Moraes
    Azevedo, Monalisa
    PITUITARY, 2012, 15 (01) : 44 - 49
  • [33] Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas
    Yarman, Sema
    Kurtulmus, Neslihan
    Bilge, Ahmet
    NEUROENDOCRINOLOGY LETTERS, 2012, 33 (03) : 340 - 346
  • [34] A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas
    Cesar Luiz Boguszewski
    Carlos Mauricio Correa dos Santos
    Kelly Suga Sakamoto
    Lilian Cassia Marini
    Admar Moraes de Souza
    Monalisa Azevedo
    Pituitary, 2012, 15 : 44 - 49
  • [35] To Withdraw or Not to Withdraw: A Structural Analysis of the Scope and Limits of Voluntary Withdrawal of Criminal Attempt in the Rome Statute
    Vuletic, Igor
    INTERNATIONAL CRIMINAL LAW REVIEW, 2020, 20 (06) : 1167 - 1192
  • [36] Cabergoline treatment of risperidone-induced hyperprolactinemia: A pilot study
    Cavallaro, R
    Cocchi, F
    Angelone, SM
    Lattuada, E
    Smeraldi, E
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (02) : 187 - 190
  • [37] Diosmin addition to cabergoline for the prevention of OHSS, will it differ? A pilot study
    Saad, A.
    Eissa, S.
    Abdellateef, W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 200 - 200
  • [38] Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas
    Auriemma, Renata S.
    Galdiero, Mariano
    Vitale, Pasquale
    Granieri, Luciana
    Lo Calzo, Fabio
    Salzano, Ciro
    Ferreri, Lucia
    Pivonello, Claudia
    Cariati, Federica
    Coppola, Giorgio
    de Angelis, Cristina
    Colao, Annamaria
    Pivonello, Rosario
    NEUROENDOCRINOLOGY, 2015, 101 (01) : 66 - 81
  • [39] Valvular Heart Disease with Long-Term Cabergoline Therapy for Prolactinomas: A Follow-Up Study.
    Dupuis, P.
    Santagata, P.
    Serri, K.
    Aris-Jilwan, N.
    Beauregard, H.
    Beauregard, C.
    Vallette, S.
    Serri, O.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [40] Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients (vol 167, pg 651, 2012)
    Vroonen, Laurent
    Jaffrain-Rea, Marie-Lise
    Petrossians, Patrick
    Tamagno, Gianluca
    Chanson, Philippe
    Vilar, Lucio
    Borson-Chazot, Francoise
    Naves, Luciana A.
    Brue, Thierry
    Gatta, Blandine
    Delemer, Brigitte
    Ciccarelli, Enrica
    Beck-Peccoz, Paolo
    Caron, Philippe
    Daly, Adrian F.
    Beckers, Albert
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (06) : 887 - 887
12345